SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-23-027841
Filing Date
2023-08-07
Accepted
2023-08-07 17:26:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 avalo424b5amendment1toatmp.htm 424B5 9263
2 GRAPHIC avalo-logoxblk.jpg GRAPHIC 48586
  Complete submission text file 0001628280-23-027841.txt   77050
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-271225 | Film No.: 231148621
SIC: 2834 Pharmaceutical Preparations